GovChime
Notice ID: 13906e25b8a34a8ca5744c528fbc690cSpecial NoticeArchived

Q--The Therapeutic Role of Soluble Adenylyl Cyclase Inhibition in Ameliorating Inf

Archived on September 19, 2026. Original response deadline: . Full description on SAM.gov.

Overview

Response deadline
10:00 AM EDT
Posted
August 28, 2026
Notice type
Special Notice
NAICS
621511: Medical Laboratories
Agency
Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH

Notice details

Office
NATIONAL INSTITUTES OF HEALTH NHLBI
Last updated
Oct 28, 2026
First published
Last updated on SAM.gov

Identifiers

Solicitation number
75N98026Q01067
Notice ID
13906e25b8a34a8ca5744c528fbc690c

Description

The Therapeutic Role of Soluble Adenylyl Cyclase Inhibition in Ameliorating Inflammatory Vascular Remodeling in Pulmonary Arterial Hypertension

Full description on SAM.gov

Award Overview

No prior contract identified

No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.

Contacts

Contracting Officer

Primary Contact

Documents

Files (1)

  • Notice_of_Intent_co_review_1.pdf

    164 KBAdded in Special Notice version 3Posted
    Download

Lifecycle

  1. 3
    Version 3Special NoticeArchivedCurrent

    Q--The Therapeutic Role of Soluble Adenylyl Cyclase Inhibition in Ameliorating Inf

    Notice 13906e25b8a34a8ca5744c528fbc690c on SAM.gov

Similar Opportunities

Title
Match
Phase
Deadline

Additional Details

Solicitation Number

75N98026Q01067

Archive Date

Sep 19, 2026

Office Address

BETHESDA, MD, 20892